1992
DOI: 10.1093/brain/115.2.495
|View full text |Cite
|
Sign up to set email alerts
|

Primary Lateral Sclerosis: Clinical Features, Neuropathology and Diagnostic Criteria

Abstract: Eight patients with a homogeneous syndrome of progressive symmetric spinobulbar spasticity were studied. Clinical features were limited to those associated with dysfunction of the descending motor tracts and included spastic quadriparesis, pseudobulbar affect, spastic dysarthria, hyper-reflexia and bilateral Babinski signs. Lower motor neuron findings were absent and higher cognitive function preserved. Median age of onset was 50.5 yrs and median disease duration was 19 yrs. Neuropathologic features (including… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

21
339
2
9

Year Published

2005
2005
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 391 publications
(371 citation statements)
references
References 42 publications
21
339
2
9
Order By: Relevance
“…It is now understood to have multiple aetiologies [Turner and Swash, 2015] and shares clinical, pathological, and genetic overlap with frontotemporal dementia (FTD) [Phukan et al, 2012]. The term primary lateral sclerosis (PLS) encompasses a very slowly progressive phenotype with pure upper motor neuron (UMN) degeneration [Pringle et al, 1992]. The improved characterization of the genetic substrate for familial ALS now enables the study of asymptomatic mutation carriers predisposed to developing ALS [Benatar et al, 2013].…”
Section: Introductionmentioning
confidence: 99%
“…It is now understood to have multiple aetiologies [Turner and Swash, 2015] and shares clinical, pathological, and genetic overlap with frontotemporal dementia (FTD) [Phukan et al, 2012]. The term primary lateral sclerosis (PLS) encompasses a very slowly progressive phenotype with pure upper motor neuron (UMN) degeneration [Pringle et al, 1992]. The improved characterization of the genetic substrate for familial ALS now enables the study of asymptomatic mutation carriers predisposed to developing ALS [Benatar et al, 2013].…”
Section: Introductionmentioning
confidence: 99%
“…In patients with ALS, a pattern of relative hypometabolism in the primary motor cortex, premotor cortices, and supplementary motor cortex but extending to extramotor areas such as the frontal and parietal lobes as well has been observed (2,4,(7)(8)(9)(10)(11). Relative hypermetabolism is observed in the mesotemporal cortex, cerebellum, and upper brain stem (2,4,7,10,(12)(13)(14).…”
mentioning
confidence: 99%
“…In families with the seipin/BSCL2 mutation, the frequency of an HSP phenotype has been observed to be as high as 10% of patients [1]. The other 46 patients in our study had symptomatic UMN involvement of the arms or bulbar region, which may suggest a diagnosis of PLS [6,10]. The results of our study indicate that the seipin/BSCL2 exon 3 mutations are not a common cause of sporadic pure HSP and PLS.…”
Section: Sirsmentioning
confidence: 46%
“…Primary lateral scherosis is a sporadic disorder of progressive spino-bulbar spasticity and may be part of the clinical spectrum of amyotrophic lateral sclerosis (ALS) [10]. Hereditary spastic paraparesis is a clinically and genetically heterogeneous group of disorders characterized by a slowly progressive spastic paraparesis [8,12].…”
Section: Sirsmentioning
confidence: 99%